Max S. Topp
- Oncology top 5%
- Pathology and Forensic Medicine top 2%
- Hematology top 2%
- Immunology top 10%
- Molecular Biology
- Co-authors
- Andreas EngertPeter BorchmannHermann EinseleJohannes DuellBastian von TresckowDennis A. EichenauerGerhard ZugmaierGeorg Kuhnert
- Topics
- Lymphoma Diagnosis and Treatment (22 papers)Chronic Lymphocytic Leukemia Research (9 papers)CAR-T cell therapy research (8 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Max S. Topp
35 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 795
- Pathology and Forensic Medicine 485
- Hematology 359
- Immunology 334
- Molecular Biology 298
Countries citing papers authored by Max S. Topp
This map shows the geographic impact of Max S. Topp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max S. Topp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max S. Topp more than expected).
Fields of papers citing papers by Max S. Topp
This network shows the impact of papers produced by Max S. Topp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max S. Topp. The network helps show where Max S. Topp may publish in the future.
Co-authorship network of co-authors of Max S. Topp
This figure shows the co-authorship network connecting the top 25 collaborators of Max S. Topp. A scholar is included among the top collaborators of Max S. Topp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max S. Topp. Max S. Topp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 43 | |
| 6 | 18 | |
| 7 | 5 | |
| 8 | 10 | |
| 9 | 2 | |
| 10 | 10 | |
| 11 | 35 | |
| 12 | The authors and a colleague reply | 9 |
| 13 | 70 | |
| 14 | 23 | |
| 15 | 1 | |
| 16 | 63 | |
| 17 | 94 | |
| 18 | 67 | |
| 19 | 3 | |
| 20 | 1 |
About Max S. Topp
Max S. Topp is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Hematology (359 citations), Oncology (795 citations) and Pathology and Forensic Medicine (485 citations). Max S. Topp has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Andreas Engert, Peter Borchmann, Hermann Einsele, Johannes Duell, Bastian von Tresckow, Dennis A. Eichenauer, Gerhard Zugmaier, Georg Kuhnert, Markus Dietlein and Michael Fuchs. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.